LCN2 and breast carcinoma: Our results show the mean concentrations of omentin-1 (98.4 ± 8.2 ng/ml) and NGAL (117.6 ± 15 ng/ml) in healthy controls and breast cancer patients (316.5 ± 293.6 ng/ml).